Drugs / CD4 CAR T cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04162340 | Jul 2019 → Oct 2021 | T-cell non-Hodgkin lymphoma | iCell Gene Therapeutics | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD4 CAR T cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04162340 ↗ |
| Modality | Cell therapy | “CD4-specific CAR T cells” NCT04162340 ↗ |
| Route | Intravenous | “by IV injection” NCT04162340 ↗ |